Corporate Entry into the Advanced and Regenerative Medicine Fields and Rising Expectations for Commercialization

A theme covering the industry environment in which entry into the advanced and regenerative medicine fields through acquisitions, investments and other means, along with R&D centered on human iPS cells, is gaining momentum and expectations and interest in commercialization are rising.